RSS

Brexit

With the UK bracing itself for Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare. Read more

News

Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma. Read more

Opinion

Adam Johnson, director of logistics specialists Tudor International Freight discusses why pharma manufacturers might lose out if the UK leaves the customs union. Read more

News

A major campaign has been launched in Brussels to help attract UK-based pharma and life science business to the Belgian capital following Brexit. Read more

News

Senior professional support lawyer Paul England and Matthew Royle, partner in the life sciences team at international law firm Taylor Wessing discuss what the introduction of a manufacturing waiver to the SPC legislation means for manufacturers. Read more

, Opinion

Rich Quelch, global head of marketing, Origin, looks at how Brexit will affect regulatory bodies in the UK and how this impacts pharmaceutical packagers. Read more

Opinion

Here, editor Reece Armstrong catches up with some of pharma’s leading names to see what else is in store for 2019. Read more

Analysis

Mark Street-Docherty, CEO of Elucigene Diagnostics, explains why the UK’s Industrial Strategy is the shining light amongst the shambles of Brexit. Read more

Opinion

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

The government is being asked to provide clarity on whether it can guarantee access to medicines and medical products in the event of a ‘no deal’ Brexit. Read more

News

Smaller companies are expected to drive innovation across Europe, according to the latest report from Pharmapack. Read more

News

An extension to Article 50 would benefit pharmaceutical manufacturers trading with Europe, according to an industry logistics expert. Read more

News

This week (16 January) saw prime minister Theresa May’s Brexit deal firmly defeated in the House of Commons bringing forward the very real possibility of a ‘no deal’ Brexit. Read more

News

Disruption for pharmaceutical manufacturers could be intensified by delays in introducing the UK’s new system for managing customs declarations, a logistics expert has said. Read more

News

As part of its ‘no deal’ Brexit plans, the Department of Health (DoH) has signed two contracts to store drugs in warehouses, queries by The Guardian have revealed. Read more

News

EPM editor Reece Armstrong examines the impact a no-deal Brexit would place on medicines supply in the UK. Read more

Opinion

Brexit, the upcoming medical device regulation (MDR) and IVDR were among the topics discussed at the MedPharmPlast Europe (MPPE) conference in Brussels. Read more

News

With the end result of Brexit fast approaching, labelling supplier Kallik looks at the implications Brexit could place on labelling and compliance in the pharmaceutical sector. Read more

Opinion

Pharmaceutical companies must make additional plans to prepare for a ‘no deal’ Brexit, health secretary Matt Hancock has said. Read more

News 1 Comments

A “Norway Plus” Brexit will be the least damaging to the pharmaceutical manufacturing sector, according to an industry logistics expert. Read more

News